Consolidated Statement of Changes in Stockholders (Deficit) Equity - USD ($)	Total	Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Balance, amount at Apr. 15, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Shares issued in reverse merger, shares		3,806,613
Shares issued in reverse merger, amount	3,807	$ 3,807	0	0	0
Shares issued for cash, shares		2,750,721
Shares issued for cash, amount	611,508	$ 2,751		608,757
Shares issued for purchase of GSL Healthcare, Inc., shares		27,932,271
Shares issued for purchase ofGSL Healthcare, Inc., amount	(27,942)	$ 27,932		(55,874)
Net Loss	(363,911)				(363,911)
Balance, shares at Aug. 31, 2020		34,489,605
Balance, amount at Aug. 31, 2020	223,462	$ 34,490	0	552,883	(363,911)
Net Loss	(1,340,347)				(1,340,347)
Common stock issued for cash	180,000		180,000
Common stock issued to consultant, shares		385,000
Common stock issued to consultant, amount	381,150	$ 385		380,765
Balance, shares at Aug. 31, 2021		34,874,605
Balance, amount at Aug. 31, 2021	(555,735)	$ 34,875	180,000	933,648	(1,704,258)
Net Loss	(2,291,263)				(2,291,263)
Issuance of previous common stock to be issued, shares		520,000
Issuance of previous common stock to be issued, amount	0	$ 520	(180,000)	179,480	0
Common stock issued to management, shares		3,000,000
Common stock issued to management, amount	1,500,000	$ 3,000		1,497,000
Common stock issued to consultants, shares		522,346
Common stock issued to consultants, amount	270,000	$ 522		269,478
Balance, shares at Mar. 31, 2022		38,916,951
Balance, amount at Mar. 31, 2022	$ (1,076,998)	$ 38,917	$ 0	$ 2,879,606	$ (3,995,521)